Reply to Yalta and Yetkin—Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
Journal: CJC Open
Year: 2022

We thank Drs Yalta and Yetkin for their article on indications for implantable cardioverter-defibrillator (ICD) therapy in patients with cardiac sarcoidosis.1Yalta K. Yetkin E. Cardiac sarcoidosis: indications for implantable cardioverter-defibrillator therapy.CJC Open. 2022; 4: 823-824Abstract Full Text Full Text PDF Scopus (1) Google Scholar They have provided a helpful summary document that nicely reviews the guidelines for ICD therapy in this population and outlines challenges of management